Investors

Financial Information

한미약품의 경영지표를 확인하실 수 있습니다.

Summarized Income Statement

(1 million won , K-IFRS)
Quarterly and yearly information
Category 2022 2021 2020 2019 2018
Sales revenue 1,331,547 1,203,186 1,075,854 1,113,650 1,015,962
Cost of sales 612,994 570,433 494,935 481,167 475,047
Gross profit 718,553 632,752 580,918 632,482 540,916
Selling general administrative expenses 406,146 361,309 319,555 334,316 291,436
Ordinary development costs 154,317 146,027 212,387 194,288 165,906
Operating Income (Loss) 158,090 125,416 48,976 103,878 83,574
Finance income 7,964 9,229 4,380 11,552 6,863
Finance cost 23,494 18,763 32,656 25,877 25,068
Other income 14,127 10,727 14,740 10,843 8,563
Other expenses 27,138 22,912 13,310 17,126 23,578
Profit (loss) before tax 121,013 103,697 22,130 83,270 50,355
Income tax expense 19,454 22,218 4,841 19,402 16,199
Profit (loss) 101,558 81,478 17,290 63,867 34,156
Other comprehensive income (12,511) 25,647 3,398 (21,284) (6,288)
Total comprehensive income 89,047 107,125 20,688 42,583 27,868